Detalhe da pesquisa
1.
Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.
Proc Natl Acad Sci U S A
; 116(16): 7926-7931, 2019 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30926668
2.
A small-molecule inhibitor of C5 complement protein.
Nat Chem Biol
; 15(7): 666-668, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209353
3.
Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma.
Proc Natl Acad Sci U S A
; 114(43): 11404-11409, 2017 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29073064
4.
Targeted protein degradation mechanisms.
Drug Discov Today Technol
; 31: 53-60, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200860
5.
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial.
Nat Med
; 29(12): 3127-3136, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957373
6.
Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy.
Nat Commun
; 12(1): 366, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446657
7.
Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases.
J Med Chem
; 63(11): 5697-5722, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073845
8.
Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition.
Cancer Discov
; 10(9): 1352-1373, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32571778
9.
Serine Metabolism Supports Macrophage IL-1ß Production.
Cell Metab
; 29(4): 1003-1011.e4, 2019 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30773464
10.
Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway.
J Med Chem
; 62(9): 4656-4668, 2019 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30995036
11.
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.
J Med Chem
; 61(4): 1622-1635, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29400470
12.
Serine Is an Essential Metabolite for Effector T Cell Expansion.
Cell Metab
; 25(2): 345-357, 2017 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28111214
13.
Evolution of a New Class of VEGFR-2 Inhibitors from Scaffold Morphing and Redesign.
ACS Med Chem Lett
; 7(4): 363-7, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27096042
14.
Core Replacements in a Potent Series of VEGFR-2 Inhibitors and Their Impact on Potency, Solubility, and hERG.
ACS Med Chem Lett
; 7(4): 357-62, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27096041
15.
The intermolecular Pauson-Khand reaction.
Angew Chem Int Ed Engl
; 44(20): 3022-37, 2005 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-15800868
16.
Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration.
J Med Chem
; 58(23): 9273-86, 2015 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26568411
17.
An effective prodrug strategy to selectively enhance ocular exposure of a cannabinoid receptor (CB1/2) agonist.
J Med Chem
; 56(13): 5464-72, 2013 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23738526
18.
Serine Is an Essential Metabolite for Effector T Cell Expansion.
Cell Metab
; 25(2): 482, 2017 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28178570
19.
Continuous flow coupling and decarboxylation reactions promoted by copper tubing.
Org Lett
; 13(2): 280-3, 2011 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21141809
20.
A cyclobutadiene equivalent in the catalytic Pauson-Khand reaction.
Angew Chem Int Ed Engl
; 43(42): 5680-2, 2004 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-15495152